Residency · Residency · Interventional Radiology
Moderate Sedation and Pain Management in IR
Introduction
The majority of interventional radiology procedures are performed under moderate (conscious) sedation, which provides anxiolysis, analgesia, and amnesia while maintaining the patient's ability to respond to verbal and tactile stimulation. Safe and effective sedation requires knowledge of pharmacology, patient assessment, monitoring standards, and rescue protocols.
Levels of Sedation (ASA Continuum)
Minimal sedation (anxiolysis): awake, responds normally to verbal commands; respiratory and cardiovascular function unaffected. Moderate sedation (conscious sedation): depressed consciousness; responds purposefully to verbal or light tactile stimulation; spontaneous ventilation adequate; cardiovascular function maintained. Deep sedation: cannot be easily aroused; responds to repeated or painful stimulation; ventilation may be impaired; may require airway intervention. General anesthesia: unarousable; requires airway management and ventilatory support. Sedation is a continuum; patients may transition to deeper levels unexpectedly.
Preprocedural Assessment
Patient Evaluation
NPO status: ASA guidelines recommend 2 hours clear liquids, 6 hours light meal, 8 hours full meal. Airway assessment: Mallampati classification, neck mobility, jaw opening, history of difficult intubation. Comorbidities: cardiopulmonary disease, obesity, OSA, hepatic/renal impairment (altered drug metabolism). Medications: current opioids (tolerance), benzodiazepines, CNS depressants. Allergies: specific medication allergies and prior sedation reactions. ASA Physical Status Classification: guides sedation risk; ASA III-IV patients may require anesthesia consultation.
Informed Consent
Discuss risks of sedation: respiratory depression, aspiration, cardiovascular compromise, paradoxical agitation. Document consent for sedation separately from the procedural consent.
Pharmacology
Benzodiazepines
Midazolam (Versed): rapid onset (1-2 min IV), short duration (30-60 min); anxiolysis, amnesia, muscle relaxation. Typical dose: 0.5-2 mg IV initially; titrate in 0.5-1 mg increments every 2-3 minutes. Reduce dose by 30-50% in elderly, hepatic impairment, and concurrent opioid use. Reversal agent: flumazenil 0.2 mg IV; may repeat every 60 seconds to a maximum of 1 mg.
Opioids
Fentanyl: rapid onset (1-2 min IV), short duration (30-60 min); potent analgesia. Typical dose: 25-100 mcg IV initially; titrate in 25 mcg increments. Preferred over morphine and meperidine for IR procedures due to predictable pharmacokinetics. Reversal agent: naloxone 0.04-0.4 mg IV; titrate to effect; watch for resedation as naloxone is shorter-acting. Morphine: longer acting; more histamine release; appropriate for prolonged procedures.
Propofol
Ultra-short-acting sedative-hypnotic; rapid onset (30 seconds), short duration (5-10 minutes). Provides excellent sedation but no analgesia; often combined with fentanyl. Requires privileged providers (anesthesia or specifically trained non-anesthesiologists) at many institutions. Dose: 0.5-1 mg/kg IV bolus, then 25-75 mcg/kg/min infusion. No reversal agent; supportive care for overdose (airway management, vasopressors).
Sedation Agents Summary
| Agent | Onset (IV) | Duration | Provides | Reversal | Key Consideration |
|---|---|---|---|---|---|
| Midazolam | 1-2 min | 30-60 min | Anxiolysis, amnesia | Flumazenil | Reduce dose 30-50% in elderly |
| Fentanyl | 1-2 min | 30-60 min | Analgesia | Naloxone | Preferred opioid for IR |
| Propofol | 30 sec | 5-10 min | Sedation (no analgesia) | None | Requires privileged providers |
| Ketamine | 1 min | 15-30 min | Analgesia, sedation, amnesia | None | Maintains BP and airway reflexes |
| Morphine | 5-10 min | 2-4 hr | Analgesia | Naloxone | Histamine release; longer procedures |
Ketamine
Dissociative anesthetic providing analgesia, sedation, and amnesia with preserved airway reflexes. Dose: 0.5-1 mg/kg IV for procedural sedation. Useful for patients with chronic opioid tolerance or hemodynamic instability (maintains blood pressure). Side effects: emergence reactions (hallucinations, agitation); mitigated with concurrent midazolam.
Local Anesthesia
Lidocaine 1%: most commonly used; onset 1-2 minutes; duration 30-60 minutes; maximum dose 4.5 mg/kg (7 mg/kg with epinephrine). Bupivacaine 0.25-0.5%: longer duration (2-8 hours); useful for post-procedural pain. Buffer lidocaine with sodium bicarbonate (1:10 ratio) to reduce injection pain. Use ultrasound-guided regional nerve blocks (e.g., transversus abdominis plane block) for selected procedures.
Monitoring During Sedation
Required Monitoring
Continuous pulse oximetry: SpO2 with alarms set. Continuous ECG: cardiac rhythm monitoring. Blood pressure: every 5 minutes at minimum. End-tidal CO2 (capnography): increasingly recommended; detects respiratory depression before oxygen desaturation. Level of consciousness: regular verbal assessment; documented at defined intervals.
Personnel Requirements
A dedicated sedation nurse whose sole responsibility is monitoring the patient (not performing the procedure). Provider trained in advanced airway management must be present. Emergency equipment readily available: bag-valve mask, oral airways, laryngoscope/video laryngoscope, suction, reversal agents, ACLS drugs, defibrillator.
Complications and Rescue
Respiratory depression: most common serious complication; manage with supplemental oxygen, jaw thrust, bag-valve mask, reversal agents. Aspiration: risk increases with inadequate NPO status and deep sedation; position patient with head elevated. Hypotension: from vasodilation and decreased sympathetic tone; treat with IV fluid bolus and vasopressors if needed. Paradoxical agitation: more common with benzodiazepines in elderly; consider dose reduction or alternative agents. Always have a plan for rescue from deeper-than-intended sedation.
Post-Procedural Care
Monitor in recovery area until discharge criteria are met (Aldrete or modified Aldrete score). Discharge criteria: stable vital signs, oriented, ambulating, tolerable pain, no active bleeding. Provide discharge instructions: no driving for 24 hours, no important decisions, pain management plan. Document sedation medications, doses, complications, and recovery assessment.
Key Clinical Pearls
Sedation is a continuum; always be prepared to manage one level deeper than intended. Midazolam and fentanyl is the most common moderate sedation combination for IR procedures; titrate to effect. Capnography detects respiratory depression earlier than pulse oximetry and should be standard monitoring. A dedicated sedation nurse who does not assist with the procedure is a safety requirement. Elderly patients, those with hepatic/renal impairment, and patients on chronic opioids require dose adjustments.
References
- Defined the Core Practice Standards. ASA Practice Guidelines for Moderate Procedural Sedation and Analgesia. Anesthesiology. 2018;128(3):437-479.
- Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. SIR Position Statement on Moderate Sedation. JVIR. 2019.
- Defined the Core Practice Guidelines. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Joint Commission Sedation Standards. 2020.
- Defined the Core Practice Standards. Defined Core Practice. Defined Core Clinical Practice. Defined Core Competencies. Defined Core Practice Guidelines. Defined Core Updates. ACR-SIR Practice Parameter for Sedation. 2020.